Use of partial area under the curve metrics to assess bioequivalence of methylphenidate multiphasic modified release formulations

AAPS J. 2012 Dec;14(4):925-6. doi: 10.1208/s12248-012-9397-7. Epub 2012 Sep 14.
No abstract available

MeSH terms

  • Area Under Curve
  • Central Nervous System Stimulants / administration & dosage
  • Central Nervous System Stimulants / pharmacokinetics*
  • Clinical Trials as Topic / methods
  • Delayed-Action Preparations
  • Drugs, Generic / administration & dosage
  • Drugs, Generic / pharmacokinetics*
  • Humans
  • Methylphenidate / administration & dosage
  • Methylphenidate / pharmacokinetics*
  • Therapeutic Equivalency

Substances

  • Central Nervous System Stimulants
  • Delayed-Action Preparations
  • Drugs, Generic
  • Methylphenidate